Acetaminophen |
Serum |
- 10–20 mg/L
- Panic: > 50 mg/L
|
66.16 |
66–132 mcmol/L |
Serum separator tube (SST) |
Acetoacetate |
Serum or urine |
Negative |
|
Negative |
SST or urine container |
Adrenocorticotropic hormone (ACTH) |
Plasma |
9–52 pg/mL (laboratory-specific) |
0.22 |
2–11 pmol/L |
Siliconized glass or plastic lavender |
Alanine aminotransferase (ALT, SGPT, GPT) |
Serum |
7–56 units/L (laboratory-specific) |
0.02 |
0.14–1.12 mckat/L (laboratory-specific) |
SST |
Albumin |
Serum |
3.4–4.7 g/dL |
10.00 |
34–47 g/L |
SST |
Aldosterone |
Serum |
Salt-loaded (120 mEq Na+/d):
|
27.74 |
|
SST |
Supine: 3–10 ng/dL |
83–277 pmol/L |
Upright: 5–30 ng/dL |
139–831 pmol/L |
Salt-depleted (20 mEq Na+/d):
|
|
Supine: 12–36 ng/dL |
332–997 pmol/L |
Upright: 17–137 ng/dL |
471–3795 pmol/L |
Urine |
Salt-loaded (120 mEq Na+/d for 3–4 days): 1.5–12.5 mcg/24 h
|
2.77 |
4.2–34.6 nmol/d |
Boric acid |
Salt-depleted (20 mEq Na+/d for 3–4 days): 18–85 mcg/24 h
|
49.9–235.5 nmol/d |
Alkaline phosphatase |
Serum |
41–133 units/L (method- and age-dependent) |
0.02 |
0.7–2.2 mckat/L (method- and age-dependent) |
SST |
Ammonia (NH3)
|
Plasma |
18–60 mcg/dL |
0.59 |
11–35 mcmol/L |
Green (iced) |
Amylase |
Serum |
20–110 units/L (laboratory-specific) |
0.02 |
0.33–1.83 mckat/L (laboratory-specific) |
SST |
Angiotensin-converting enzyme (ACE) |
Serum |
12–35 units/L (method-dependent) |
16.67 |
< 590 nkat/L (method-dependent) |
SST |
Antithrombin III (AT III) |
Plasma |
- 84–123% (qualitative)
- 22–39 mg/dL (quantitative)
|
|
|
Blue |
1-Antitrypsin
|
Serum |
110–270 mg/dL |
0.01 |
1.1–2.7 g/L |
SST |
Aspartate aminotransferase (AST, SGOT, GOT) |
Serum |
0–35 units/L (laboratory-specific) |
0.02 |
0–0.58 mckat/L (laboratory-specific) |
SST |
Basophil count |
Whole blood |
0.01–0.12 x 103/mcL
|
1.00 |
0.01–0.12 x 109/L
|
Lavender |
Bilirubin |
Serum |
- Total: 0.1–1.2 mg/dL
- Direct (conjugated to glucuronide): 0.1–0.5 mg/dL
- Indirect (unconjugated): 0.1–0.7 mg/dL
|
17.10 |
- 2–21 mcmol/L
- < 8 mcmol/L
- < 12 mcmol/L
|
SST |
Blood urea nitrogen (BUN) |
Serum |
8–20 mg/dL |
0.36 |
2.9–7.1 mmol/L |
SST |
-Natriuretic peptide |
Whole blood |
< 50 pg/mL |
|
|
Lavender |
C-peptide |
Serum |
0.8–4.0 ng/mL |
1.00 |
0.8–4.0 mcg/L |
- Iced (fasting)
- Gold SST
|
C-reactive protein |
Serum |
<5 mg/L |
1.00 |
<5 mg/L |
SST |
Calcitonin |
Plasma |
- Male: 0–11.5 pg/mL
- Female: 0–4.6 pg/mL
|
1.00 |
- Male: 0–11.5 ng/L
- Female: 0–4.6 ng/L
|
- Green
- Gold SST
|
Calcium (Ca2+)
|
Serum |
- 8.5–10.5 mg/dL
- Panic: < 6.5 or > 13.5 mg/dL
|
0.25 |
2.1–2.6 mmol/L |
SST |
Calcium (ionized) |
Serum |
4.6–5.3 mg/dL |
0.25 |
1.15–1.32 mmol/L |
Green (anaerobic) |
Calcium (UCa)
|
Urine |
100–300 mg/d |
0.025 |
2.5–7.5 mmol/d |
Urine bottle containing hydrochloric acid |
Carbon dioxide, partial pressure (Pco2)
|
Whole blood |
32–48 mm Hg |
0.13 |
4.26–6.38 kPa |
Heparinized syringe (iced) |
Carbon dioxide (CO2), total (bicarbonate)
|
Serum |
- 22–32 mEq/L
- Panic: < 15 or > 40 mEq/L
|
1.00 |
- 22–32 mmol/L
- Panic: < 15 or > 40 mmol/L
|
SST |
Carboxyhemoglobin (HbCO) |
Whole blood |
< 9% of total hemoglobin (Hb) |
0.01 |
< 0.09 fraction of total hemoglobin |
Green |
Carcinoembryonic antigen (CEA) |
Serum |
0–5 ng/mL |
1.00 |
0–5 mcg/L |
SST |
CD4 T cell count |
Whole blood |
359–1725 cells/mcL |
|
|
Lavender (complete blood count and differential and % CD4 required) |
Ceruloplasmin |
Serum |
20–60 mg/dL (laboratory-specific) |
10.00 |
200–600 mg/L |
SST |
Chloride (Cl–)
|
Serum |
101–112 mEq/L |
1.00 |
101–112 mmol/L |
SST |
Cholesterol |
Serum |
- Desirable: < 200 mg/dL
- Borderline: 200–239 mg/dL
- High risk: > 240 mg/dL
|
0.03 |
- Desirable: < 5.2 mmol/L
- Borderline: 5.2–6.1 mmol/L
- High risk: > 6.2 mmol/L
|
SST |
Chorionic gonadotropin, -subunit (-hCG), quantitative |
Serum |
Males and nonpregnant females: undetectable or < 5 mU/mL |
1.00 |
Males and nonpregnant females: undetectable or < 5 units/L |
SST |
Complement C3 |
Serum |
64–166 mg/dL |
10.00 |
640–1660 mg/L |
SST |
Complement C4 |
Serum |
15–45 mg/dL |
10.00 |
150–450 mg/L |
SST |
Complement CH50 |
Serum |
(Laboratory-specific) |
|
|
Red |
Cortisol |
Serum |
8:00 AM: 5–20 mcg/dL |
27.59 |
140–550 nmol/L |
SST |
Cortisol (urinary free) |
Urine |
10–110 mcg/24 h |
2.76 |
30–300 nmol/d |
Urine bottle containing boric acid |
Creatine kinase (CK) |
Serum |
32–267 units/L (method-dependent) |
0.02 |
0.53–4.45 mckat/L (method-dependent) |
SST |
Creatine kinase MB (CKMB) |
Serum |
- < 16 units/L or < 4% of total CK (laboratory-specific)
- Mass units: 0–7 mcg/L
|
0.04 |
< 0.27 mckat/L |
SST |
Creatinine (Cr) |
Serum |
0.6–1.2 mg/dL |
83.3 |
50–100 mcmol/L |
SST |
Creatinine clearance (ClCr)
|
See Collection column. |
Adults: 90–140 mL/min/1.73 m2 body surface area (BSA)
|
0.017 |
1.5–2.3 mL/s/1.73 m2 BSA
|
Carefully timed 24-hour urine and simultaneous serum or plasma creatinine sample |
Cryoglobulins |
Serum |
< 0.12 mg/dL |
|
|
Red (at 37°C) |
Eosinophil count |
Whole blood |
0.04–0.5 x 103/mcL
|
1.00 |
0.04–0.5 x 109/L
|
Lavender |
Erythrocyte count (RBC count) |
Whole blood |
4.7–6.1 x 106/mcL
|
1.00 |
4.7–6.1 x 1012/L
|
Lavender |
Erythrocyte sedimentation rate |
Whole blood |
- Male: < 10 mm/h
- Female: < 15 mm/h (laboratory-specific)
|
|
Same |
Lavender |
Erythropoietin (EPO) |
Serum |
5–20 mU/mL |
1.00 |
5–20 units/L |
SST |
Ethanol |
Serum |
- mg/dL
- Legal "driving under the influence" in many states is defined as > 80 mg/dL (> 17 mmol/L) blood alcohol level; serum alcohol levels are 10–35% higher than blood alcohol levels
|
0.217 |
mmol/L |
SST |
Factor VIII assay |
Plasma |
40–150% of normal (varies with age) |
|
|
Blue |
Fecal fat |
Stool |
- Random: < 60 droplets of fat per high-power field
- 72-hour: < 7 g/d
|
|
|
- Qualitative: Random stool sample
- Quantitative: 72-hour collection following 2-day dietary fat regimen
|
Ferritin |
Serum |
- Male: 16–300 ng/mL
- Female: 4–161 ng/mL
|
1.00 |
- Male: 16–300 mcg/L
- Female: 4–161 mcg/L
|
SST |
-Fetoprotein (AFP) |
Serum |
0–15 ng/mL |
1.00 |
0–15 mcg/L |
SST |
Fibrin D-dimers |
Plasma |
Negative |
|
|
Blue |
Fibrinogen (functional) |
Plasma |
- 175–433 mg/dL
- Panic: < 75 mg/dL
|
0.01 |
1.75–4.3 g/L |
Blue |
Folic acid (red cells) |
Whole blood |
165–760 ng/mL |
2.27 |
370–1720 nmol/L |
Lavender |
Follicle-stimulating hormone (FSH) |
Serum |
Female: |
1.00 |
Female: |
SST |
Follicular phase 4–13 mU/mL |
4–13 units/L |
Luteal phase 2–13 mU/mL |
2–13 units/L |
Midcycle 5–22 mU/mL |
5–22 units/L |
Postmenopausal 30–138 mU/mL |
30–138 units/L |
Male: 1–10 mU/mL (laboratory-specific) |
Male: 1–10 units/L (laboratory-specific) |
Free erythrocyte protoporphyrin (FEP) |
Whole blood |
< 35 mcg/dL (method-dependent) |
|
|
Lavender |
Fructosamine |
Serum |
|
|
190–270 mcmol/L |
SST |
-Glutamyltranspeptidase (GGT) |
Serum |
9–85 units/L (laboratory-specific) |
0.02 |
0.15–1.42 mckat/L (laboratory-specific) |
SST |
Gastrin |
Serum |
< 100 pg/mL (laboratory-specific) |
1.00 |
< 100 ng/L |
SST |
Glucose |
Serum |
- 60–110 mg/dL
- Panic: < 40 or > 500 mg/dL
|
0.055 |
3.3–6.1 mmol/L |
- (Fasting)
- SST
|
Glucose-6-phosphate dehydrogenase (G6PD) screen |
Whole blood |
5–14 units/g Hb |
0.02 |
0.1–0.28 mckat/L |
Lavender |
Glutamine |
Cerebrospinal fluid (CSF) |
- 6–15 mg/dL
- Panic: > 40 mg/dL
|
68.5 |
411–1028 mcmol/L |
Collect CSF in a plastic tube |
Glycated (glycosylated) hemoglobin (HbA1c)
|
Serum |
3.9–6.9% (method- dependent) |
|
|
Lavender |
Growth hormone (GH) |
Serum |
0–5 ng/mL |
1.00 |
0–5 mcg/L |
SST |
Haptoglobin |
Serum |
46–316 mg/dL |
0.01 |
0.5–3.2 g/L |
SST |
HDL cholesterol |
Serum |
- Male: 27–67 mg/dL
- Female: 34–88 mg/dL
|
0.026 |
- 0.7–1.73 mmol/L
- 0.88–2.28 mmol/L
|
SST |
Helicobacter pylori antibody |
Serum |
Negative |
|
|
SST |
Hematocrit (Hct) |
Whole blood |
- Male: 39–49%
- Female: 35–45% (age-dependent)
|
0.01 |
- Male: 0.39–0.49
- Female: 0.35–0.45
|
Lavender |
Hemoglobin A1c (See Glycated Hemoglobin)
|
Serum |
|
|
|
|
Hemoglobin A2 (HbA2)
|
Whole blood |
1.5–3.5% of total hemoglobin |
0.01 |
0.015–0.035 |
Lavender |
Hemoglobin electrophoresis |
Whole blood |
- HbA: > 95%
- HbA2: 1.5–3.5%
|
|
|
Lavender |
Hemoglobin, fetal (HbF) |
Whole blood |
Adult: < 2% (varies with age) |
|
|
Lavender |
Hemoglobin, total (Hb) |
Whole blood |
- Male: 13.6–17.5 g/dL
- Female: 12.0–15.5 g/dL
- Panic: 7 g/dL (age-dependent)
|
10.00 |
- Male: 136–175 g/L
- Female: 120–155 g/L
|
Lavender |
Hemosiderin |
Urine |
Negative |
|
|
Urine container |
HIV viral load |
Plasma |
Negative |
|
|
Lavender |
Homocysteine |
Plasma |
4–12 mcmol/L |
1.00 |
4–12 mcmol/L |
Lavender |
5-Hydroxyindoleacetic acid (5-HIAA) |
Urine |
2–8 mg/24 h |
5.23 |
10–40 mcmol/d |
Urine bottle containing hydrochloric acid |
IgG index |
Serum and CSF |
0.29–0.59 ratio |
|
|
SST and plastic tube for CSF |
Immunoglobulins (Ig) |
Serum |
- IgA: 78–367 mg/dL
- IgG: 583–1761 mg/dL
- IgM: 52–335 mg/dL
|
0.01 |
- IgA: 0.78–3.67 g/L
- IgG: 5.83–17.6 g/L
- IgM: 0.52–3.35 g/L
|
SST |
Insulin, immunoreactive |
Serum |
6–35 mcU/mL |
7.18 |
42–243 pmol/L |
SST |
Insulin-like growth factor-1 |
Plasma |
123–463 ng/mL (age- and sex-dependent) |
1.0 |
123–463 mcg/L |
SST |
Iron (Fe2+)
|
Serum |
50–175 mcg/dL |
0.18 |
9–31 mcmol/L |
SST |
Iron-binding capacity, total (TIBC) |
Serum |
250–460 mcg/dL |
0.18 |
45–82 mcmol/L |
SST |
Lactate dehydrogenase (LDH) |
Serum |
88–230 units/L (laboratory-specific) |
0.02 |
1.46–3.82 mckat/L (laboratory-specific) |
SST |
Lactic acid (lactate) |
Venous blood |
0.5–2.0 mEq/L |
1.00 |
0.5–2.0 mmol/L |
Gray |
LDL cholesterol |
Serum |
< 130 mg/dL |
0.026 |
< 3.37 mmol/L |
SST |
Lead (Pb) |
Whole blood |
- Child: < 25 mcg/dL
- Adult: < 40 mcg/dL
|
0.05 |
- Child: < 1.21 mcmol/L
- Adult: < 1.93 mcmol/L
|
Navy |
Lecithin/sphingomyelin (L/S) ratio |
Amniotic fluid |
> 2.0 (method-dependent) |
|
|
Collect in a plastic tube |
Leukocyte alkaline phosphatase (LAP) |
Whole blood |
- 40–130
- Based on 0 to 4+ rating of 100 polymorphonuclear neutrophils stained for alkaline phosphatase
|
|
|
Green |
Leukocyte (white blood cell) count, total (WBC count) |
Whole blood |
- 4.8–10.8 x 103/mcL
- Panic: < 1.5 x 103/mcL
|
1.00 |
4.8–10.8 x 109/L
|
Lavender |
Lipase |
Serum |
0–160 units/L (laboratory-specific) |
0.02 |
0–2.66 mckat/L (laboratory-specific) |
SST |
Luteinizing hormone (LH) |
Serum |
Female: |
1.00 |
|
SST |
Follicular phase 1–18 mU/mL |
1–18 units/L |
Luteal phase 0.4–20 mU/mL |
0.4–20 units/L |
Midcycle 24–105 mU/mL |
24–105 units/L |
Postmenopausal 15–62 mU/mL |
15–62 units/L |
Male: 1–10 mU/mL (laboratory-specific) |
Male: 1–10 units/L (laboratory-specific) |
Lymphocyte count |
Whole blood |
0.8–3.5 x 103/mcL
|
1.00 |
0.8–3.5 x 109/L
|
Lavender |
Magnesium (Mg2+)
|
Serum |
- 1.8–3.0 mg/dL
- Panic: < 0.5 or > 4.5 mg/dL
|
0.41 |
0.75–1.25 mmol/L |
SST |
Mean corpuscular hemoglobin (MCH) |
Whole blood |
26–34 pg |
|
|
Lavender |
Mean corpuscular hemoglobin concentration (MCHC) |
Whole blood |
31–36 g/dL |
10.00 |
310–360 g/L |
Lavender |
Mean corpuscular volume (MCV) |
Whole blood |
80–100 fL |
|
|
Lavender |
Metanephrines |
Urine |
0.3–0.9 mg/24 h |
5.46 |
1.6–4.9 mcmol/d |
Urine bottle containing hydrochloric acid |
Methemoglobin (MetHb) |
Whole blood |
< 1% of total hemoglobin |
0.01 |
< 0.01 fraction of total hemoglobin |
Green |
Methylmalonic acid |
Serum |
0–0.05 mg/L |
8.475 |
0–0.4 mcmol/L |
SST |
Monocyte count |
Whole blood |
0.2–0.8 x 103/mcL
|
1.00 |
0.2–0.8 x 109/L
|
Lavender |
Neutrophil count |
Whole blood |
2.2–8.6 x 103/mcL
|
1.00 |
2.2–8.6 x 109/L
|
Lavender |
Osmolality |
Serum |
- 275–293 mosm/kg H2O
- Panic: < 240 or > 320 mosm/kg H2O
|
1.00 |
275–293 mmol/kg H2O
|
SST |
Urine |
Random: 100–900 mosm/kg H2O
|
1.00 |
Random: 100–900 mmol/kg H2O
|
Urine container |
Oxygen, partial pressure (Po2)
|
Whole blood |
83–108 mm Hg |
0.13 |
11.04–14.36 kPa |
Heparinized syringe (iced) |
Parathyroid hormone (PTH) |
Serum |
Intact PTH: 11–54 pg/mL (laboratory-specific) |
0.11 |
Intact PTH: 1.2–5.7 pmol/L (laboratory-specific) |
Red |
Partial thromboplastin time, activated (PTT) |
Plasma |
- 25–35 seconds (range varies)
- Panic: 60 seconds
|
|
|
Blue |
pH |
Whole blood |
- Arterial: 7.35–7.45
- Venous: 7.31–7.41
|
|
|
Heparinized syringe (iced) |
Phosphorus |
Serum |
- 2.5–4.5 mg/dL
- Panic: < 1.0 mg/dL
|
0.32 |
0.8–1.45 mmol/L |
SST |
Platelet count (Plt) |
Whole blood |
- 150–450 x 103/mcL
- Panic: < 25 x 103/mcL
|
1.0 |
- 150–450 x 109/L
- Panic: < 25 x 109/L
|
Lavender |
Platelet-associated IgG |
Whole blood |
Negative |
|
|
Lavender |
Porphobilinogen (PBG) |
Urine |
Negative |
|
|
Protect from light |
Potassium (K+)
|
Serum |
- 3.5–5.0 mEq/L
- Panic: < 3.0 or > 6.0 mEq/L
|
1.00 |
3.5–5.0 mmol/L |
SST |
Prolactin (PRL) |
Serum |
< 20 ng/mL |
1.00 |
< 20 mcg/L |
SST |
Prostate-specific antigen (PSA) |
Serum |
0–4 ng/mL |
1.00 |
0–4 mcg/L |
SST |
Protein C |
Plasma |
71–176% |
|
|
Blue |
Protein electrophoresis |
Serum |
- Adults:
- Albumin: 3.3–4.7 g/dL
- 1: 0.1–0.4 g/dL
- 2: 0.3–0.9 g/dL
- 2: 0.7–1.5 g/dL
- : 0.5–1.4 g/dL
|
10.00 |
- 33–47 g/L
- 1–4 g/L
- 3–9 g/L
- 7–15 g/L
- 5–14 g/L
|
SST |
Protein S (antigen) |
Plasma |
76–178% |
|
|
Blue |
Protein, total |
Serum |
6.0–8.0 g/dL |
10.00 |
60–80 g/L |
SST |
Prothrombin time (PT) |
Whole blood |
- 11–15 seconds
- Panic: 30 seconds (laboratory-specific)
|
|
|
Blue |
Red blood cell count |
Whole blood |
4.7–6.1 x 106/mcL
|
1.00 |
4.7–6.1 x 1012/L
|
Lavender |
Red cell volume |
Whole blood |
25–35 mL/kg |
|
|
Green |
Renin activity (PRA) |
Plasma |
- High-sodium diet (75–150 mEq Na+/d):
- Supine: 0.2–2.3 ng/mL/h
- Standing: 1.3–4.0 ng/mL/h)
- Low-sodium diet (30–75 mEq Na+/d):
- Standing: 4.0–7.7 ng/mL/h)
|
|
|
Lavender |
Reptilase clotting time |
Plasma |
13–19 seconds |
|
|
Blue |
Reticulocyte count |
Whole blood |
33–137 x 103/mcL
|
1.00 |
33–137 x 109/L
|
Lavender |
Russell's viper venom clotting time (dilute) (RVVT) |
Plasma |
24–37 seconds |
|
|
Blue |
Salicylate (aspirin, others) |
Serum |
- 20–30 mg/dL
- Panic: > 35 mg/dL
|
10.00 |
200–300 mg/L |
SST |
Sodium (Na+)
|
Serum |
- 135–145 mEq/L
- Panic: < 125 or > 155 mEq/L
|
1.00 |
135–145 mmol/L |
SST |
Testosterone |
Serum |
- Male: 175–781 ng/dL
- Female: 10–75 ng/dL
|
0.0347 |
- Male: 6–27 nmol/L
- Female: 0.3–2.6 nmol/L
|
SST |
Thrombin time |
Plasma |
8–12 seconds (laboratory-specific) |
|
|
Blue |
Thyroglobulin |
Serum |
3–42 ng/mL |
1.00 |
3–42 mcg/L |
SST |
Thyroid-stimulating hormone (TSH) |
Serum |
0.4–6 mcU/mL |
1.00 |
0.4–6 mU/L |
SST |
Thyroid-stimulating hormone receptor antibody (TSH-R Ab [stim]) |
Serum |
< 130% of basal activity; based on cAMP generation in thyroid cell tissue culture |
|
|
|
Thyroxine, free (FT4)
|
Serum |
9–24 pmol/L (varies with method) |
|
|
SST |
Thyroxine (T4), total
|
Serum |
5–11 mcg/dL |
12.80 |
64–142 nmol/L |
SST |
Thyroxine index, free (FT4I)
|
Serum |
6.5–12.5 |
|
|
SST |
Transferrin |
Serum |
190–375 mg/dL |
0.01 |
1.9–3.75 g/L |
SST |
Triglycerides |
Serum |
< 165 mg/dL |
0.01 |
< 1.8 mmol/L |
SST (fasting) |
Triiodothyronine (T3), total
|
Serum |
95–190 ng/dL |
0.015 |
1.5–2.9 nmol/L |
SST |
Troponin-I (cTnI) |
Serum |
< 0.05 ng/mL |
|
|
SST |
Uric acid |
Serum |
- Male: 2.4–7.4 mg/dL
- Female: 1.4–5.8 mg/dL
|
59.48 |
- Male: 140–440 mcmol/L
- Female: 80–350 mcmol/L
|
SST |
Vanillylmandelic acid (VMA) |
Urine |
2–7 mg/24 h |
5.05 |
10–35 mcmol/d |
Urine bottle containing hydrochloric acid |
Vitamin B12
|
Serum |
140–820 pg/mL |
0.74 |
100–600 pmol/L |
SST |
Vitamin B12 absorption test (Schilling test)
|
24-hour urine |
Excretion of > 8% of administered dose |
|
|
Urine bottle |
Vitamin D, 25-hydroxy (25[OH]D) |
Serum |
10–50 ng/mL |
2.5 |
25–125 nmol/L |
SST |
Vitamin D, 1,25-dihydroxy (1,25[OH]2D)
|
Serum |
20–76 pg/mL |
2.4 |
48–182 pmol/L |
SST |
White blood cell count |
Whole blood |
4.8–10.8 x 103/mcL
|
1.00 |
4.8–10.8 x 109/L
|
Lavender |